Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/790051/000079005121000175/csl-20210630.htm
October 2023
October 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
February 2023
October 2022
PRESS RELEASE | ![]() |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/790051/000079005121000175/csl-20210630.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Carlisle Companies Inc.
Carlisle Companies Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Rating
Learn More![]()
Driven by our strategic plan, Vision 2025, Carlisle is committed to generating superior shareholder returns and maintaining a balanced capital deployment approach, including investments in our businesses, strategic acquisitions, share repurchases and continued dividend increases.
29 Financing Activities Cash used in financing activities of $284.5 million in the first six months of 2021 primarily reflected share repurchases of $265.6 million and cash dividend payments of $56.0 million, reflecting the increased quarterly dividend of $0.525 per share.
30 Non-GAAP Financial Measures EBIT, Adjusted EBIT, Adjusted EBITDA and Adjusted EBITDA Margin Earnings before interest and taxes ("EBIT"), adjusted EBIT, adjusted earnings before income, taxes, depreciation and amortization ("EBITDA") and adjusted EBITDA margin are intended to provide investors and others with information about the Company's and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items.
Selling and Administrative Expenses The increase in selling and administrative expenses in the second quarter and first six months of 2021 primarily reflected higher medical costs, higher incentive compensation costs and wage inflation.
The Company's and its segments' EBIT, adjusted EBIT, adjusted EBITDA and adjusted EBITDA margin follows.
Interest Income Interest income decreased...Read more
23 Gross Margin Gross margin...Read more
On May 25, 2021, we...Read more
The decrease in operating margin...Read more
CFT's operating margin percentage performance...Read more
CFT's operating margin percentage performance...Read more
Diluted earnings per share from...Read more
At the new facility, CCM...Read more
As of the 22 end...Read more
Other Non-operating Expense (Income), net...Read more
26 CCM's operating margin percentage...Read more
CCM's operating margin percentage increase...Read more
These efforts were clearly demonstrated...Read more
These efforts were clearly demonstrated...Read more
CIT's revenue decline in the...Read more
CIT's revenue decline in the...Read more
In addition, such statements could...Read more
Given expanding global vaccine rollout,...Read more
Given expanding global vaccine rollout,...Read more
Carlisle Fluid Technologies ("CFT") delivered...Read more
Carlisle Fluid Technologies ("CFT") CFT...Read more
CIT's operating margin percentage decreased...Read more
Sources and Uses of Cash...Read more
All of CCM's platforms delivered...Read more
CIT's operating margin percentage decrease...Read more
The effective income tax rate...Read more
Consistent with Carlisle's Vision 2025...Read more
As a result, management believes...Read more
Given our adherence to strict...Read more
CCM's revenue increased in the...Read more
CCM's revenue increased in the...Read more
Carlisle's positive second quarter results...Read more
Henry will augment Carlisle Construction...Read more
Income Taxes The effective income...Read more
CFT's revenue increased in the...Read more
CFT's revenue increased in the...Read more
Interest Expense, net Interest expense,...Read more
Such statements are made based...Read more
25 Income (Loss) from Discontinued...Read more
We generated $171.5 million in...Read more
Consistent with Carlisle's Vision 2025...Read more
At the discretion of management,...Read more
Research and Development Expenses Research...Read more
Taken together with the improving...Read more
Taken together with the improving...Read more
We may access the capital...Read more
Also included in selling and...Read more
Over a year removed from...Read more
We also anticipate we will...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Carlisle Companies Inc provided additional information to their SEC Filing as exhibits
Ticker: CSL
CIK: 790051
Form Type: 10-Q Quarterly Report
Accession Number: 0000790051-21-000175
Submitted to the SEC: Tue Jul 27 2021 2:08:50 PM EST
Accepted by the SEC: Tue Jul 27 2021
Period: Wednesday, June 30, 2021
Industry: Fabricated Rubber Products